This inventor holds 1 USPTO granted patent. Top assignees: Sichuan University, Yaopharma Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 262 
1 out of 5 Years Active: 2019
Title: Yao Fu - Innovator in Tumor Targeting Polypeptides
Introduction
Yao Fu is a notable inventor based in Sichuan, China. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that target tumors. His innovative work has the potential to enhance cancer treatment methodologies.
Latest Patents
Yao Fu holds a patent for a polypeptide designed to target tumors. This patent describes an nRGD polypeptide formed by connecting alanine-alanine-asparagine (AAN) with a polypeptide containing arginine-glycine-aspartic acid (RGD). The nRGD polypeptide is capable of targeting tumor vessels, tumor cells, and tumor-associated macrophages, facilitating the targeted delivery of therapeutic agents to tumors.
Career Highlights
Throughout his career, Yao Fu has been associated with prominent institutions such as Sichuan University and Yaopharma Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Yao Fu has collaborated with esteemed colleagues, including Zhirong Zhang and Tao Gong. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Yao Fu's contributions to the field of tumor-targeting polypeptides exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for improving cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile